Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study.

ABSTRACT:

SUBMITTER: Reville PK 

PROVIDER: S-EPMC7969746 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature